People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medicus Pharma Ltd. | — | Pharma | Series A | $15.9M | $61.0M | 2023 |
Frank J. Lavelle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank J. Lavelle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William L. Ashton | 1 | 3 |
| Edward J. Brennan | 1 | 3 |
| Robert J. Ciaruffoli | 1 | 1 |
| Carolyn J. Bonner | 1 | 1 |
| Raza J. Bokhari | 1 | 1 |
| Barry J. Fishman | 1 | 1 |
| Erica J. Monaco | 1 | 1 |
| Sara R. May | 1 | 1 |
| James J. Quinlan | 1 | 1 |
| Larry Kaiser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.